Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.70
Bid: 27.60
Ask: 28.05
Change: -0.40 (-1.42%)
Spread: 0.45 (1.63%)
Open: 27.45
High: 28.05
Low: 26.95
Prev. Close: 28.10
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership Agreement

27 Mar 2012 14:00

RNS Number : 1858A
IQE PLC
27 March 2012
 



IQE plc

 

IQE selected as partner in $2m Australian Solar Institute programme

 

Cardiff, UK, 27 March 2012: IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of advanced semiconductor wafer products and services to the semiconductor industry, has been selected as a key CPV wafer supplier by Australian CPV company Silex Systems as part of a $2m programme to develop high efficiency multi-junction solar cells on low-cost large-area silicon substrates.

 

Silex Systems (ASX: SLX) received the $2 million grant from the Australian Solar Institute to support the company's development of solar cell technology which could reduce energy production costs by up to 20%.

 

The aim of the programme is to develop, fabricate, and test novel next-generation multiple-junction solar cells used in the evolving utility scale Concentrating Photovoltaic (CPV) solar power station industry.

 

The key differentiator is the development of a new virtual 'Germanium' substrate wafer-based substrate where a thin layer of Ge is deposited on a Silicon wafer. This will reduce the cost and potentially improve the efficiency of the multiple-junction cells in CPV applications. The new substrates and resulting CPV cell structures will be fully characterised and analysed in the lab and then tested in on-sun in field equipment.

 

The grant from the Australian Solar Institute (ASI) which was established by the Australian Government in 2009 is for the development of high efficiency multi-junction solar cells on low cost large area silicon substrates. The program, by Silex's wholly owned subsidiary Solar Systems, has the potential to reduce the cost of energy production from Concentrating Photovoltaic technologies by up to 20%.

 

Solar Systems will supplement the $2 million grant by providing about $3 million in project funding, with $2 million of in-kind support and $1 million in cash contributions over the three year project duration.

 

Project partner and Silex subsidiary Translucent will provide large area silicon substrate technology for the project, allowing for commercialisation of the technology to be fast tracked.

 

Dr. Andrew Johnson, IQE's CPV Technology Director said:

 

"Silex Systems' selection of IQE as a partner for this programme clearly demonstrates that we are recognised as a key global player in CPV wafer products for advanced, high efficiency solar energy generation. This programme builds on our advanced capabilities in germanium on silicon for CPV applications that we launched in 2010 and compliments the range of CPV technologies in which we are active."

 

Other key CPV partners in the programme include Boeing-owned Spectrolab and Emcore Corporation for multi-junction cell production facilities.

 

These partnerships will allow for volume production of the solar cells, which will be incorporated into Solar Systems' dense array system to characterise the performance of the new CPV modules at the Bridgewater Test Facility in central Victoria.

 

 

 

FURTHER INFORMATION

 

IQE: www.iqep.com

Silex Systems: http://www.silex.com.au/

Australian Solar Institute: www.australiansolarinstitute.com.au/

 

 

CONTACTS:

IQE plc (+44 29 2083 9400)

Press: Chris Meadows

Technical: Dr Andrew Johnson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUQCWUPPGPM
Date   Source Headline
27th Jul 20062:47 pmRNSGrant of share options
20th Jul 20067:02 amRNSTrading Statement
20th Jul 20067:01 amRNSAcquisition
7th Jul 20062:46 pmRNSChange of Adviser
5th Jun 200610:32 amRNSDirector/PDMR Shareholding
30th May 20067:01 amRNSTrading Update
23rd May 200612:58 pmRNSAdditional Listing
19th May 20062:59 pmRNSHolding(s) in Company
8th May 20061:00 pmRNSAGM Notice & Board Appt
3rd May 20068:49 amRNSHolding(s) in Company
21st Apr 20066:01 pmRNSAdditional Listing
4th Apr 200612:45 pmRNSAdditional Listing
30th Mar 20064:25 pmRNSHolding(s) in Company
29th Mar 20061:51 pmRNSDirector/PDMR Shareholding
28th Mar 200611:27 amRNSHolding(s) in Company
20th Mar 20067:01 amRNSFinal Results
10th Mar 20064:33 pmRNSChange of Results Date
1st Mar 20067:01 amRNSNotice of Results
27th Jan 20067:01 amRNSPre-Close Trading Update
27th Jan 20067:01 amRNSContract Win
20th Dec 200511:58 amRNSAdditional Listing
26th Oct 20052:06 pmRNSHolding(s) in Company
20th Oct 20053:57 pmRNSDirector/PDMR Shareholding
10th Oct 20059:38 amRNSDirector/PDMR Shareholding
12th Sep 20053:09 pmRNSHolding(s) in Company
24th Aug 20057:00 amRNSInterim Results
19th Aug 200511:46 amRNSAdditional Listing
29th Jul 20057:00 amRNSNotice of Results
22nd Jul 20055:23 pmRNSHolding(s) in Company
20th Jul 20051:17 pmRNSHolding(s) in Company
19th Jul 200510:42 amRNSHolding(s) in Company
18th Jul 20053:52 pmRNSHolding(s) in Company
15th Jul 200512:54 pmRNSAdditional Listing
12th Jul 20057:30 amRNSIndustry Award Win
28th Jun 200511:47 amRNSAdditional Listing- Replace
28th Jun 200510:12 amRNSAdditional Listing
17th Jun 20059:48 amRNSHolding(s) in Company
16th Jun 200511:09 amRNSHolding(s) in Company
26th May 200511:53 amRNSAnnual Report and Accounts
25th May 20051:15 pmRNSAGM Statement
18th Apr 20053:24 pmRNSAdditional Listing
22nd Mar 20057:02 amRNSFinal Results
28th Feb 20059:33 amRNSNotice of Results
4th Feb 20051:18 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSTrading Statement
10th Jan 200511:35 amRNSAdd. Listing/Director s/hldng

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.